0

Autoinjectors Market by Application, End-user, and Geography - Forecast and Analysis 2021-2025

  • Published: Mar 2021
  • Pages: 120
  • SKU: IRTNTR70391
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

The autoinjectors market share is expected to increase by USD 82.91 billion from 2021 to 2025, and the market's growth momentum will accelerate at a CAGR of 24%.

This autoinjectors market research report provides valuable insights on the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentations by application (anaphylaxis, multiple sclerosis, rheumatoid arthritis, and others) and geography (North America, Europe, Asia, and ROW). The autoinjectors market report also offers information on several market vendors, including Amgen Inc., Antares Pharma Inc., Bayer AG, Becton, Dickinson and Co., Eli Lilly and Co., GlaxoSmithKline Plc, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Ypsomed Holding AG, among others.

What will the Autoinjectors Market Size be During the Forecast Period?

Autoinjectors Market Size

Download the Free Report Sample to Unlock the Autoinjectors Market Size for the Forecast Period and Other Important Statistics

 

Autoinjectors Market: Key Drivers and Challenges

Based on our research output, there has been a neutral impact on the market growth during and post the COVID-19 era. The increasing prevalence of allergies and need for immediate care is notably driving the autoinjectors market's growth, although factors such as the side-effects of autoinjectors may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic's impact on the autoinjectors industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Autoinjectors Market Driver

Globally, the prevalence of allergies to food items, pollens, food additives, latex, and dust and the risk of contracting anaphylaxis caused by these factors are increasing. Extreme symptoms of allergies require emergency treatment. Epinephrine is known to have an immediate effect on allergies. Such drugs help reduce the effect of life-threatening allergies in case of an emergency. Autoinjectors can treat symptoms with a dose of epinephrine. These autoinjectors help restore normal breathing, increase blood pressure if it's dropping, and reduce swelling. With the increasing occurrence of allergies, the growth prospects of epinephrine autoinjectors are likely to rise, as they can be self-administered during sudden anaphylactic attacks. 

Key Autoinjectors Market Challenge

The use of autoinjectors causes several side-effects, such as infection, hypertension, hypotension, myalgia, headache, and diarrhea. Patients with chemotherapy-induced anemia exhibit fatigue, edema, nausea, vomiting, fever, and increased occurrence of hypertension. Other allergic reactions may include dyspnea, bronchospasm, tongue edema, skin rash, and urticaria. Thus, the associated side-effects can impact the adoption of autoinjectors and encourage patients to opt for alternatives with less severe side-effects. 

This autoinjectors market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.

Who are the Major Autoinjectors Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

  • Amgen Inc.
  • Antares Pharma Inc.
  • Bayer AG
  • Becton, Dickinson and Co.
  • Eli Lilly and Co.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Ypsomed Holding AG

 

This statistical study of the autoinjectors market encompasses successful business strategies deployed by the key vendors. The autoinjectors market is fragmented, and the vendors are deploying growth strategies such as launching low-priced authorized generics of epinephrine autoinjectors to compete in the market.

To make the most of the opportunities and recover from the post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments while maintaining their positions in the slow-growing segments.

The autoinjectors market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. 

Which are the Key Regions for Autoinjectors Market?

Autoinjectors Market Market segmentation by region

For more insights on the market share of various regions Request for a FREE sample now!

41% of the market's growth will originate from North America during the forecast period. The US and Canada are the key markets for autoinjectors in North America. Market growth in this region will be faster than the growth of the market in Asia and ROW.

By geography, North America is expected to account for the largest share of the global autoinjectors market during the forecast period because of the presence of a well-established healthcare system comprising clinics and hospitals. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

What are the Revenue-generating Application Segments in the Autoinjectors Market?

Autoinjectors Market Segmentation

To gain further insights on the market contribution of various segments Request for a FREE sample

The autoinjectors market share growth by the anaphylaxis segment will be significant during the forecast period. By application, the anaphylaxis segment generates the highest revenue because of the increasing prevalence of anaphylaxis and food allergies at a global level. 

This report provides an accurate prediction of the contribution of all the segments to the growth of the autoinjectors market's size and actionable market insights on the post-COVID-19 impact on each segment.

You may be interested in:

 

Epinephrine Autoinjector market - The market share is expected to increase by USD 1.37 billion from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 7.84%. 

Autoinjectors Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Accelerate at a CAGR of 24%

Market growth 2021-2025

USD 82.91 billion

Market structure

Fragmented

YoY growth (%)

23.57

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 41%

Key consumer countries

The US, the UK, Germany, Canada, and China

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Amgen Inc., Antares Pharma Inc., Bayer AG, Becton, Dickinson and Co., Eli Lilly and Co., GlaxoSmithKline Plc, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Ypsomed Holding AG

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Autoinjectors Market Report?

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive the autoinjectors market's growth during the next five years
  • Precise estimation of the autoinjectors market's size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the autoinjectors industry across North America, Europe, Asia, and ROW
  • A thorough analysis of the market's competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of the autoinjectors market's vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Executive Summary

    Market Landscape

    • Market ecosystem
    • Value chain analysis

    Market Sizing

    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025

    Five Forces Analysis

    • Five forces summary
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition

    Market Segmentation by Application

    • Market segments
    • Comparison by Application
    • Anaphylaxis - Market size and forecast 2020-2025
    • Multiple sclerosis - Market size and forecast 2020-2025
    • Rheumatoid arthritis - Market size and forecast 2020-2025
    • Others - Market size and forecast 2020-2025
    • Market opportunity by Application

    Market Segmentation by End-user

    • Hospitals and clinics
    • Self-administration

    Customer Landscape

      Geographic Landscape

      • Geographic segmentation
      • Geographic comparison
      • North America - Market size and forecast 2020-2025
      • Europe - Market size and forecast 2020-2025
      • Asia - Market size and forecast 2020-2025
      • ROW - Market size and forecast 2020-2025
      • Impact of COVID-19 pandemic and recovery in the global market
      • Key leading countries
      • Market opportunity by geography
      • Market drivers
      • Market challenges
      • Market trends

      Vendor Landscape

      • Overview
      • Vendor landscape
      • Landscape disruption

      Vendor Analysis

      • Vendors covered
      • Market positioning of vendors
      • Amgen Inc.
      • Antares Pharma Inc.
      • Bayer AG
      • Eli Lilly and Co.
      • GlaxoSmithKline Plc
      • Johnson & Johnson
      • Teva Pharmaceutical Industries Ltd.
      • Viatris Inc.
      • Ypsomed Holding AG

      Appendix

      • Scope of the report
      • Currency conversion rates for US$
      • Research methodology
      • List of abbreviations

      Research Framework

      Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

      TechnavioINFORMATION SOURCES

      Primary sources

      • Manufacturers and suppliers
      • Channel partners
      • Industry experts
      • Strategic decision makers

      Secondary sources

      • Industry journals and periodicals
      • Government data
      • Financial reports of key industry players
      • Historical data
      • Press releases
      Technavio

      TechnavioDATA ANALYSIS

      Data Synthesis

      • Collation of data
      • Estimation of key figures
      • Analysis of derived insights

      Data Validation

      • Triangulation with data models
      • Reference against proprietary databases
      • Corroboration with industry experts
      Technavio

      TechnavioREPORT WRITING

      Qualitative

      • Market drivers
      • Market challenges
      • Market trends
      • Five forces analysis

      Quantitative

      • Market size and forecast
      • Market segmentation
      • Geographical insights
      • Competitive landscape
      Interested in this report?
      Get your sample now!
      Autoinjectors market growth will increase by $82.91 billion during 2020-2025.
      The autoinjectors market is expected to grow at a CAGR of 24.22% during 2020-2025.
      Technavio has segmented the autoinjectors market by application (Anaphylaxis, Multiple sclerosis, Rheumatoid arthritis, and Others) and geographic (North America, Europe, Asia, and ROW).
      Amgen Inc., Antares Pharma Inc., Bayer AG, Becton, Dickinson and Co., Eli Lilly and Co., GlaxoSmithKline Plc, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Viatris Inc., Ypsomed Holding AG are a few of the key vendors in the autoinjectors market.
      North America will register the highest growth rate of 40.82% among the other regions. Therefore, the autoinjectors market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
      The key factors driving the autoinjectors market growth are:
      • Increasing prevalence of allergies and need for immediate care
      The autoinjectors market vendors should focus on grabbing business opportunities from the anaphylaxis segment as it accounted for the largest market share in the base year.
      • What are the key global market and the regional market share?
      • What are the revenue-generating key market segments?
      • What are the key factors driving and challenging this market’s growth?
      • Who are the key market vendors and their growth strategies?
      • What are the latest trends influencing the growth of this market?
      • What are the variables influencing the market growth in the primary regions?
      • What are the factors influencing the growth of the parent market?
      • Off-the-shelf research reports
      • Reports can be tailored to meet the customer's needs
      • Trusted by more than 100 fortune 500 organizations
      • Information about the market's key drivers, trends, and challenges
      • Parent market analysis
      • Every week, 50,000 people visit our subscription platform
      • Detailed vendors report with competitive landscape
      • Covid-19 impact and recovery analysis
      • Data on revenue-generating market segments
      • Details on the market shares of various regions
      • Five-force market analysis

      Certified ISO 9001 : 2015

      We are ISO recognized

      We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

      We are GDPR and CCPA compliant

      We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

      Safe and Secure SSL Encrypted
      Technavio

      info
      close
      • Single:

        One user only.
        Quick & easy download option

      • Enterprise:

        Unlimited user access (Within your organization)
        Complimentary Customization Included

      2500 USD

      Technavio Get the report (PDF) sent to your email within minutes.

      Subscribe & Save

      Get lifetime access to our
      Technavio Insights

      Customized Report as per your Business Needs

      • Our analysts will work directly with you and understand your needs
      • Get data on specified regions or segments, competitor and Vendors
      • Data will be formatted and presented as per your requirements
      • We offer $1000 worth of FREE customization at the time of purchase

      Let us help you make report more suited to your requirements.

      • Get a competitive breakdown as per your niche industry
      • Customize the data with various metrics that meet your business prerequisite
      • Understand Revenue Sources, Customers and many more
      • Details on Market Share
      • These customizations are done in a short amount of time by our analysts and industry experts
      Technavio
      Enquire Before Buying
      17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>